It's been a terrible, horrible, no good, awful past seven months on Wall Street. Most companies are feeling the effects of macroeconomic headwinds such as inflation and supply chain issues, and few are managing to perform well on the market.
Thankfully, there are some companies in the black for the year. Two companies in this group are AbbVie (NYSE: ABBV) and Jazz Pharmaceuticals (NASDAQ: JAZZ) . Both of these healthcare stocks also present attractive prospects. Let's consider why they are worth buying today.
For further details see:
2 Top Healthcare Stocks Defying the Bear Market